Ravi Biolife Private Limited, a active private limited company, was established on 31 December 2020 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24299MH2020PTC352827. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹5.01 Cr.
It upholds a compliant status. Employing 71 professional, Its leadership includes Vinod Singhania (Director), Siddharth Singhania (Director), Harshvardhan Singhania (Additional Director). Past directors included Devang Rajesh Singhania. It holds ₹7.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 121, 12 Floor Plot-209, Atlanta Building Jamnalal Bajaj Marg, Nariman Point, Mumbai, Maharashtra, 400021.
U24299MH2020PTC352827
352827
31 December 2020
₹15.00 Cr
₹5.01 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Ravi Biolife Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vinod Singhania | Director | 31 Dec 2020 | Current |
| Siddharth Singhania | Director | 31 Dec 2020 | Current |
| Harshvardhan Singhania | Additional Director | 16 Oct 2024 | Current |
| Devang Rajesh Singhania | Director | 01 Apr 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Dec 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ravi Biolife Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 395.12% decrease in profit. The company's net worth observed a substantial decline by a decrease of 74.14%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Ravi Biolife had a promoter holding of 4.00% and a public holding of 96.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹70,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2024 | Axis Bank Limited | ₹7.00 Cr | Open |
Explore comprehensive loan charge details -
Ravi Biolife has a workforce of 71 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ravi Biolife, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ravi Biolife's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Axis Bank Limited of Rs. 7.00 Cr registered on 31 Dec 2024 with Charge ID 101037434 was modified on 19 Apr 2025. was completed.
Progress on A charge with Axis Bank Limited amounted to Rs. 7.00 Cr with Charge ID 101037434 was registered on 31 Dec 2024. was documented.
The activity Harshvardhan Singhania was appointed as a Additional Director was appointed as a Additional Director on 16 Oct 2024 & has been associated with this company since 1 year 1 month . was completed.
The activity Ravi Biolife Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Ravi Biolife Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity Devang Rajesh Singhania was appointed as a Director was appointed as a Director on 01 Apr 2021 & has been associated with this company since 4 years 8 months . was completed.
The CIN of Ravi Biolife Private Limited is U24299MH2020PTC352827.
Ravi Biolife Private Limited is headquartered at 121, 12 Floor Plot-209, Atlanta Building Jamnalal Bajaj Marg, Nariman Point, Mumbai, Maharashtra, 400021.
Ravi Biolife Private Limited was incorporated on 31 December 2020.
The current directors of Ravi Biolife Private Limited are
The primary industry of Ravi Biolife Private Limited is Manufacturing.
Ravi Biolife Private Limited is unlisted.
The authorized capital of Ravi Biolife Private Limited is ₹15.00 Cr, and the paid-up capital is ₹5.01 Cr.
The compliance status of Ravi Biolife Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX